Accessibility Menu
 
Retractable Technologies logo

Retractable Technologies

(NYSEMKT) RVP

Current Price$0.71
Market Cap$19.93M
Since IPO (2001)-95%
5 Year-95%
1 Year-7%
1 Month+1%

Retractable Technologies Financials at a Glance

Market Cap

$19.93M

Revenue (TTM)

$38.27M

Net Income (TTM)

$12.57M

EPS (TTM)

$-0.43

P/E Ratio

-1.56

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Price

$0.71

Volume

0

Open

$0.71

Previous Close

$0.71

Daily Range

$0.71 - $0.71

52-Week Range

$0.62 - $1.14

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Retractable Technologies

Industry

Healthcare Equipment and Supplies

Employees

201

CEO

Thomas J. Shaw

Headquarters

Little Elm, TX 75068-5295, US

RVP Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

-53%

Net Income Margin

-33%

Return on Equity

-16%

Return on Capital

-15%

Return on Assets

-9%

Earnings Yield

-64.10%

Dividend Yield

0.00%

Payout Ratio

-1.83%

Stock Overview

Market Cap

$19.93M

Shares Outstanding

29.94M

Volume

0

Short Interest

0.00%

Avg. Volume

53.12K

Financials (TTM)

Gross Profit

$47.05K

Operating Income

$20.22M

EBITDA

$12.45M

Operating Cash Flow

$7.06M

Capital Expenditure

$535.64K

Free Cash Flow

$7.60M

Cash & ST Invst.

$36.97M

Total Debt

$365.28K

Retractable Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$9.44M

+4.0%

Gross Profit

$1.53M

+38.7%

Gross Margin

-16.21%

N/A

Market Cap

$19.93M

N/A

Market Cap/Employee

$90.16K

N/A

Employees

221

N/A

Net Income

$2.35M

-162.3%

EBITDA

$4.61M

-181.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$36.61M

-15.5%

Accounts Receivable

$7.90M

-9.8%

Inventory

$17.19M

-10.4%

Long Term Debt

$530.37K

-41.1%

Short Term Debt

$371.28K

+11.7%

Return on Assets

-8.81%

N/A

Return on Invested Capital

-15.20%

N/A

Free Cash Flow

$623.11K

+55.6%

Operating Cash Flow

$596.54K

+46.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NRSNNeuroSense Therapeutics Ltd.
$0.76+0.66%
HBIOHarvard Bioscience, Inc.
$5.09+4.52%
XCURExicure, Inc.
$4.18-1.75%
FEMYFemasys Inc.
$0.42-0.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
NVDANvidia
$175.75+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%

Questions About RVP

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.